Preoperative vitamin D replacement therapy in primary hyperparathyroidism: Safe and beneficial?

Surgery

Volumn 144, Issue 6, 2008, Pages 852-859

  Grubbs, Elizabeth G ^a   Rafeeq, Safia ^a   Jimenez, Camilo ^a   Feng, Lei ^a   Lee, Jeffrey E ^a   Evans, Douglas B ^a   Perrier, Nancy D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ERGOCALCIFEROL; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG SAFETY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; BIOLOGICAL MARKERS; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 56449118815     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.06.032     Document Type: Article

References (24)

1. Feldman D. Vitamin D, parathyroid hormone, and calcium: a complex regulatory network. Am J Med 107 (1999) 637-639
2. Holick M.F. Vitamin D deficiency. N Engl J Med 357 (2007) 266-281
3. Chapuy M., and Meunier P. Vitamin D insufficiency in adults and the elderly. In: Feldmen D., Glorieux F.H., and Pike J.W. (Eds). Vitamin D (1997), Academic Press, San Diego, CA
4. Davies M., Heys S.E., Selby P.L., Berry J.L., and Mawer E.B. Increased catabolism of 25-hydroxyvitamin D in patients with partial gastrectomy and elevated 1,25-dihydroxyvitamin D levels. Implications for metabolic bone disease. J Clin Endocrinol Metab 82 (1997) 209-212
5. Clements M.R., Davies M., Hayes M.E., Hickey C.D., Lumb G.A., Mawer E.B., et al. The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin D deficiency. Clin Endocrinol (1992) 3717-3727
6. Silverberg S.J., Shane E., Dempster D.W., and Bilezikian J.P. The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107 (1999) 561-567
7. Grey A., Lucas J., Horne A., Gamble G., Davidson J.S., and Reid I.R. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 90 (2005) 2122-2126
8. Rao D.S., Agarwal G., Talpos G.B., Phillips E.R., Bandeira F., Mishra S.K., et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res 17 (2002) N75-N80
9. Rao D.S., Honasoge M., Divine G.W., Phillips E.R., Lee M.W., Ansari M.R., et al. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85 (2000) 1054-1058
10. Nordenstrom E., Westerdahl J., Lindergard B., Lindblom P., and Bergenfelz A. Multifactorial risk profile for bone fractures in primary hyperparathyroidism. World J Surg 26 (2002) 1463-1467
11. Buchwald P.C., Westin G., and Akerstrom G. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review). Int J Mol Med 15 (2005) 701-706
12. Bilezikian J.P. Primary hyperparathyroidism. When to observe and when to operate. Endocrinol Metab Clin North Am 29 (2000) 465-478
13. Beyer T.D., Solorzano C.C., Prinz R.A., Babu A., Nilubol N., and Patel S. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery 141 (2007) 777-783
14. Caron N.R., Sturgeon C., and Clark O.H. Persistent and recurrent hyperparathyroidism. Curr Treat Options Oncol 5 (2004) 335-345
15. Goldner W.S., O'Dorisio T.M., Dillon J.S., and Mason E.E. Severe metabolic bone disease as a long-term complication of obesity surgery. Obes Surg 12 (2002) 685-692
16. Goldner W.S., Stoner J.A., Thompson J., Taylor K., Larson L., Erickson J., et al. Prevalence of vitamin d insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg 18 (2008) 145-150
17. Moosgaard B., Vestergaard P., Heickendorff L., Melsen F., Christiansen P., and Mosekilde L. Vitamin D status, seasonal variations, parathyroid adenomaweight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol 63 (2005) 506-513
18. Milas M., Wagner K., Easley K.A., Siperstein A., and Weber C.J. Double adenomas revisited: nonuniform distribution favors enlarged superior parathyroids (fourth pouch disease). Surgery 134 (2003) 995-1003
19. Irvin III G.L., Carneiro D.M., and Solorzano C.C. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239 (2004) 704-708
20. Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90 (2005) 3215-3224
21. Lips P., Hosking D., Lippuner K., Norquist J.M., Wehren L., Maalouf G., et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260 (2006) 245-254
22. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Eng J Med 338 (1998) 777-783
23. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69 (1999) 842-856
24. Stewart Z.A., Blackford A., Somervell H., Friedman K., Garrett-Mayer E., Dackiw A.P., et al. 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 138 (2005) 1018-1025